Letters, Testimony & Comments

Good morning Chairman Casey, Vice Chairman Brady, Ranking Member DeMint, Ranking Member Hinchey, Members of the Committee, ladies, and...
May 25 2011
Re: Request for Comments on the Strategy for American Innovation Subject: Innovation Strategy RFI Email: competitiveness@doc.gov Dear...
April 1 2011
Dear President Obama: The organizations below urge your Administration to maintain robust funding levels for the Department of...
January 11 2011
Access to Early Capital In the United States and globally, commercial development of biotechnology relies on the continuing...
May 27 2010
Good morning Chairwoman Velázquez, Ranking Member Graves, Members of the Committee, the Staff of the Committee, ladies and...
October 14 2009
Good morning Chairman Wu, Ranking Member Smith, Members of the Committee, ladies and gentleman. I am Jim Greenwood, President and CEO of...
April 23 2009
To Hector Barreto, Administrator, U.S. Small Business Administration
November 4 2003
To Hector Barreto, Administrator, U.S. Small Business Administration
October 21 2003
Administrator, U.S. Small Business Administration
May 13 2003
January 24 2013
To ensure transparency and communication between patients and their treatment teams, BIO believes that certain safeguards should guide substitution policies for interchangeable biologics under state law as well.
May 25 2011
Representatives of the bioscience industry testified before the U.S. Congress Joint Economic Committee today, as part of a hearing entitled Driving Innovation and Job Growth through the Life Sciences Industry.
April 1 2011
BIO submitted comments in response to the Request for Comments on the Strategy for American Innovation issued by the U.S. Department of Commerce. BIO addressed policies relating to government research and development, entrepreneurship, intellectual property, and incentives to innovate. BIO encouraged the Department of Commerce to help create an environment conducive to risk-taking and one that will unleash the tremendous potential of biotechnology.
January 11 2011
BIO and 23 other renewable energy groups have joined together in a letter to the White House requesting full funding and support of the Department of Agriculture's renewable energy program in the President's Budget for fiscal year 2012.
May 27 2010
The paper highlights factors that contribute to enabling environments for promising technologies to gain access to early capital.
April 16 2013
Bill would allow emerging biotech companies to maintain a working relationship with their independent auditor.
October 26 2011
 BIO Commends Governor Nixon and Missouri Legislature for Commitment to Industry
September 9 2011
BIO President and CEO Jim Greenwood released the following statement on President Obama’s speech to Congress last night on “The American Jobs Act.”
June 29 2011
“Unleashing the Promise of Biotechnology: Advancing American Innovation to Cure Disease and Save Lives” Provides Roadmap for Transformative Policy Changes
April 19 2011
The federal Renewable Fuel Standard provides the stable market support and pricing system necessary to attract private investment to the development of advanced biofuels.